DeepMind's AlphaGenome 2 predicts DNA variant effects cell type by cell type
Google DeepMind says AlphaGenome 2, trained on more than 100 million cell profiles, found 30% of causal variants on an immune-cell dataset versus 16% for the original. It is open via API for non-commercial research.
Why it matters: Biotech teams can trial it now for research. DeepMind says it is not validated for clinical or diagnostic use, so keep it out of patient decisions.
From Drop #080 · Wed, Nov 11, 2026 · Evening